Aperiomics
Sterling
About Aperiomics
Aperiomics is the only company of its kind and scope in the world. We are revolutionizing the way that medical professionals around the world identify infections. Supported by the National Science Foundation, Aperiomics identifies every known bacteria, virus, fungus, and parasite through Deep Shotgun Metagenomic Sequencing, using our world renown database containing over 37,000 microbes. We help doctors and their patients identify the causes of infections that other tests cannot identify, thus streamlining the path to a positive clinical outcome. Many patients that we have helped were sick for years with no understanding of why. Patients and their physicians often contact Aperiomics after hearing about our life-changing success stories. Aperiomics was named Life Science Innovator of the Year in 2016 and International Start Up of the Year in 2018.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $5.2M
- Funding stage: Early Stage Venture
- Last round: Convertible Note (Dec 2020)
- Website: aperiomics.com
- Phone: 703-229-0406
Industries & Categories
Bioinformatics, Biotechnology, Genetics, Health Care, Health Diagnostics
Social Profiles
Canonical: https://fsome.com/organization/aperiomics-37613 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.